FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals, pharmacy students, nurse practitioner students, physician assistants, and medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On April 14, 2016, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: “The Pregnancy and Lactation Labeling Rule (PLLR)”. The featured speaker was Tamara Johnson MD, MS Acting Medical team Leader FDA/CDER/OND/DPMH.
Dr. Johnson discussed the history of pregnancy and lactation labeling and explained the rationale for the new labeling requirements, described the new elements of prescription drug labeling to improve communication to the prescriber about potential risks with drug use during pregnancy and lactation and identified the new location for recommendations on pregnancy testing, contraception use, and infertility effects in prescription drug labeling.